Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has raised A$4 million to support commercial licensing activity, clinical ...
Recce Pharmaceuticals gains key approval to advance diabetic foot infection trial to pivotal Phase 3
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has secured Human Research Ethics Committee (HREC) approval to advance its ...
Recce Pharmaceuticals is raising up to $8 million to advance its portfolio of synthetic anti-infective products designed to ...
Recce shares are under heavy pressure as investors weigh up the companyโs latest capital raise and funding needs.
Expansion into the Middle East and North Africa (MENA) region is now firmly in Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF)'s sights after it took a step toward commercialising its R327 Topical Gel, ...
Recce Pharmaceuticals Ltd. (AU:RCE) has released an update. Recce Pharmaceuticals Ltd (ASX:RCE) successfully passed a resolution via poll at their Special General Meeting, marking a significant step ...
Recce, a new film & TV recommendation app designed to cure content overload and bring clarity to viewer decision fatigue, has launched. With an intuitive interface, and a community centric approach, ...
Sole lead manager Ord Minnett was offering new shares at 40¢ a pop on Wednesday, representing a 13 per cent discount to the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results